SCHEMBL22824884

SCHEMBL22824884

CC(C)NC(=S)C(C)N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10211106 0.75 — —
SCHEMBL15028118 0.74 DPP4 (1.00) —
SCHEMBL12340738 0.74 DPP4 (1.00) —
SCHEMBL13254038 0.71 DPP4 (0.47) —
Isopropylamine SCHEMBL11662673 0.71 DPP4 (0.36) —
SCHEMBL12778012 0.71 — —
SCHEMBL329850 0.69 — —
Isopropylamine SCHEMBL11664033 0.69 DPP4 (0.34) —
SCHEMBL3069346 0.67 CA12 (0.35) —
SCHEMBL437705 0.67 NPSR1 (0.44) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11793885-B2 Substituted benzo[5,6][1,4]diazepino[1,2-a]indoles for the treatment of proliferative disorders IMMUNOGEN, INC. (US) 2023-10-24 — — US disclosed
US-20200397914-A1 BENZODIAZEPINE DERIVATIVES IMMUNOGEN, INC. 2020-12-24 — — US disclosed
Send feedback